A. Martínez-arán, E. Vieta, F. Colom, C. Torrent, J. Sánchez-moreno et al., Cognitive impairment in euthymic bipolar patients: implications for clinical and functional outcome, Bipolar Disord, vol.6, issue.3, pp.224-256, 2004.

A. Martínez-arán, E. Vieta, M. Reinares, F. Colom, C. Torrent et al., Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder, Am J Psychiatry, vol.161, issue.2, pp.262-70, 2004.

E. Bora, M. Yucel, and C. Pantelis, Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives, J Affect, 2009.

V. V. Dias, V. Balanzá-martinez, M. G. Soeiro-de-souza, R. A. Moreno, M. L. Figueira et al.,

R. Vieira and E. Vieta, Pharmacological approaches in bipolar disorders and the impact on cognition: a critical overview, Acta Psychiatr Scand, vol.126, issue.5, pp.315-346, 2012.

L. V. Kessing, J. L. Forman, and P. K. Andersen, Does lithium protect against dementia?, Bipolar Disord

A. Sabater, A. C. García-blanco, H. M. Verdet, P. Sierra, J. Ribes et al.,

L. Livianos, Comparative neurocognitive effects of lithium and anticonvulsants in long-term stable bipolar patients, J Affect Disord, vol.190, pp.34-40, 2016.

L. N. Yatham, I. J. Torres, G. S. Malhi, S. Frangou, D. C. Glahn et al.,

A. Arán, S. Dittmann, J. F. Goldberg, A. Ozerdem, O. Aydemir et al., The International Society for Bipolar Disorders-Battery for Assessment of Neurocognition, Bipolar Disord, vol.12, issue.4, pp.351-63, 2010.

D. M. Hafeman, K. D. Chang, A. S. Garrett, E. M. Sanders, and M. L. Phillips, Effects of medication on neuroimaging findings in bipolar disorder: an updated review, Bipolar Disord, vol.14, issue.4, pp.375-410, 2012.

F. Marmol, Litium : Bipolar disorder and neurodegenerative diseases possible cellular mechanisms of the therapeutic effects of lithium, pp.1761-1771

J. S. Rao, G. J. Harry, S. I. Rapoport, and H. W. Kim, Increased excitotoxicity and neuroinflammatory Rev, vol.33, pp.336-54, 2009.

V. Senturk, C. Goker, A. Bilgic, S. Olmez, H. Tugcu et al., Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate, Bipolar Disord, vol.9, issue.1, pp.136-180, 2007.

E. Vieta, M. Reinares, and A. R. Rosa, Staging Bipolar Disorder, Neurotox Res, vol.19, issue.2, pp.279-85, 2011.

D. J. Martino, S. A. Strejilevich, and F. Manes, Neurocognitive functioning in early-onset and late-onset older patients with euthymic bipolar disorder, Int J Geriatr Psychiatry, vol.28, issue.2, pp.142-150, 2013.

B. Cullen, J. Ward, N. A. Graham, I. J. Deary, J. P. Pell et al., Prevalence and correlates of cognitive impairment in euthymic adults with bipolar disorder : a systematic review, J Affect Disord, vol.205, pp.165-181, 2016.

E. Vieta, F. Colom, B. Corbella, A. Martínez-arán, M. Reinares et al., Clinical correlates of psychiatric comorbidity in bipolar I patients, Bipolar Disord, vol.3, issue.5, pp.253-261, 2001.

K. R. Boylan, P. J. Bieling, M. Marriott, H. Begin, L. T. Young et al., Impact of comorbid anxiety disorders on outcome in a cohort of patients with bipolar disorder, J Clin Psychiatry, 2004.

V. Balanzá-martínez, G. Selva, A. Martínez-arán, J. Prickaerts, J. Salazar et al.,

E. Vieta and R. Tabarés-seisdedos, Neurocognition in bipolar disorders-a closer look at comorbidities and medications, Eur J Pharmacol, vol.626, issue.1, pp.87-96, 2010.

B. Levy, B. A. Monzani, M. R. Stephansky, and R. D. Weiss, Neurocognitive impairment in patients with co-occurring bipolar disorder and alcohol dependence upon discharge from inpatient care, Psychiatry Res, vol.161, issue.1, pp.28-35, 2008.

C. E. Bearden, D. C. Glahn, S. Caetano, R. L. Olvera, M. Fonseca et al.,

J. C. Soares, Evidence for disruption in prefrontal cortical functions in juvenile bipolar disorder, Bipolar Disord, vol.9, issue.1, pp.145-59, 2007.

M. N. Pavuluri, O. Connor, M. M. Harral, E. M. Moss, M. Sweeney et al., Impact of neurocognitive function on academic difficulties in pediatric bipolar disorder: A clinical translation, Biol Psychiatry, vol.60, issue.9, pp.951-957, 2006.

J. M. Azorin, L. C. Perret, E. Fakra, S. Tassy, N. Simon et al., Alcohol use and bipolar disorders: Risk factors associated with their co-occurrence and sequence of onsets. Drug Alcohol Depend, Bipolar Disord, vol.179, issue.2, pp.113-138, 2009.

N. Huxley and R. Baldessarini, Disability and its treatment in bipolar disorder patients, Bipolar Disord, vol.9, issue.1-2, pp.183-96, 2007.

M. S. Bauer, G. F. Kirk, C. Gavin, and W. O. Williford, Determinants of functional outcome and healthcare costs in bipolar disorder: a high-intensity follow-up study, J Affect Disord, vol.65, issue.3, pp.231-272, 2001.

G. S. Malhi, M. Tanious, P. Das, C. M. Coulston, and M. Berk, Potential mechanisms of action of lithium in bipolar disorder. Current understanding, CNS Drugs, vol.27, issue.2, pp.135-53, 2013.

J. P. Hennion, M. A. El-masri, M. O. Huff, and R. S. El-mailakh, Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage, Bipolar Disord, vol.4, issue.3, pp.201-207, 2002.

X. Li, T. A. Ketter, and M. A. Frye, Synaptic, intracellular, and neuroprotective mechanisms of anticonvulsants: are they relevant for the treatment and course of bipolar disorders?, J Affect Disord, vol.69, issue.1-3, pp.1-14, 2002.

O. V. Forlenza, B. S. Diniz, M. Radanovic, F. S. Santos, L. L. Talib et al., Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial, Curr Alzheimer Res, vol.198, issue.5, p.46, 2006.

C. Daban, A. Martínez-arán, C. Torrent, J. Sánchez-moreno, and J. M. Goikolea,

M. , C. F. Vieta, and E. , Cognitive functioning in bipolar patients receiving lamotrigine: preliminary results, Clin Psychopharmacol, vol.26, issue.2, pp.178-81, 2006.

A. P. Aldenkamp, D. Krom, M. Reijs, and R. , Newer antiepileptic drugs and cognitive issues

, Epilepsia, vol.44, pp.21-30, 2003.

G. Bersani, A. Quartini, D. Zullo, A. Iannitelli, A. P. Wingo et al., Potential neuroprotective effect of lithium in bipolar patients evaluated by neuropsychological assessment : preliminary results, Hum Psychopharmacol, vol.31, issue.1, pp.1588-97, 2009.

G. J. Moore, B. M. Cortese, D. A. Glitz, C. Zajac-benitez, J. A. Quiroz et al.,

H. K. , A longitudinal study of the effects of lithium treatment on prefrontal and subgenual prefrontal gray matter volume in treatment-responsive bipolar disorder patientS, J Clin Psychiatry, vol.70, issue.5, pp.699-705, 2009.

T. Hajek, M. Bauer, C. Simhandl, J. Rybakowski, C. O'donovan et al.,

A. , Y. K. Uher, R. Young, L. T. Macqueen, G. et al., Neuroprotective effect of lithium on hippocampal volumes in bipolar disorder independent of long-term treatment response, Psychol Med

, , vol.44, pp.507-524, 2013.

K. Muralidharan, J. M. Kozicky, L. E. Silveira, I. J. Torres, and L. N. Yatham, Are cognitive deficits similar in remitted early bipolar I disorder patients treated with lithium or valproate? Data from the STOP-EM study, vol.25, 2014.

P. S. Tsai, I. C. Liu, C. H. Chiu, C. J. Huang, and M. Y. Wang, Effect of valproic acid on dementia onset in patients with bipolar disorder. Affect Disord, vol.201, pp.131-137, 2016.

A. Pfenning, A. M. Young, T. Macqueen, G. Rybakowski, J. Suwalska et al.,

B. , H. T. O'donovan, C. Wittekind, D. Von-quillfeldt, S. Ploch et al., Prophylactic lithium treatment and cognitive performance in patients with a long history of bipolar illness: no simple answers in complex disease-treatment interplay, Int J Bipolar Disord, vol.2, p.1, 2014.

E. Stip, J. Dufresne, I. Lussier, and L. Yatham, A double-blind, placebo-controlled study of the effects of lithium on cognition in healthy subjects: mild and selective effects on learning, J Affect Disord, vol.60, issue.3, pp.147-57, 2000.

E. Bora, M. Yücel, and C. Pantelis, Cognitive impairment in affective psychoses: a meta-analysis

, Schizophr Bull, vol.36, issue.1, pp.112-137, 2009.

C. Simonsen, K. Sundet, A. Vaskinn, A. B. Birkenaes, and J. A. Engh,

H. Faerden, . Jónsdóttir, A. Petter, S. Ringen, I. Opjordsmoen et al., Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group, Schizophr Bull, vol.37, issue.1, pp.73-83, 2009.

C. Demmo, T. V. Lagerberg, S. R. Aminoff, T. Hellvin, L. R. Kvitland et al.,

I. Melle and T. Ueland, History of psychosis and previous episodes as potential explanatory factors for neurocognitive impairment in first-treatment bipolar I disorder, Bipolar Disord, vol.18, issue.2, pp.136-183, 2016.

S. Flowers, K. Ryan, Z. Lai, M. Mcinnisand, and V. Ellingrod, Interaction between COMT rs5993883 and second generation antipsychotics is linked to decreases in verbal cognition and cognitive control in bipolar disorder, BMC Psychology, vol.4, 2016.

L. V. Kessing, L. Søndergård, J. L. Forman, and P. K. Andersen, Antidepressants and dementia, J Affect Disord, vol.117, issue.1-2, pp.24-33, 2009.

K. Heser, T. Luck, S. Röhr, B. Wiese, H. Kaduszkiewicz et al.,

J. Werle, C. Brettschneider, H. H. König, A. Fuchs, M. Pentzek et al., Potentially inappropriate medication: Association between the use of antidepressant drugs and the subsequent risk for dementia, J Affect Disord, vol.226, pp.28-35, 2017.

S. Billioti-de-gage, B. Bégaud, F. Bazin, H. Verdoux, J. F. Dartigues et al.,

V. Balanzá-martínez, G. Selva, A. Martínez-arán, J. Prickaerts, J. Salazar et al., Benzodiazepine use and risk of dementia: prospective population based study, BMJ, vol.345, p.6231, 2012.

E. Vieta, T. Tabarés-seisdedos-r-;-wykes, V. Huddy, C. Cellard, S. R. Mcgurk et al., A meta-analysis of cognitive remediation for schizophrenia : methodology and effect sizes, Eur J Pharmacol, vol.626, issue.1, pp.87-96, 2009.

, , vol.168, pp.472-85, 2011.